By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GATC Biotech subsidiary LifeCodexx said today that it has completed the recruitment of more than 500 blood samples for a clinical study of its non-invasive prenatal diagnostic test for trisomy 21.

The Konstanz, Germany-based company said that the prospective and blinded study will evaluate its sequencing-based PraenaTest against "conventional invasive methods."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.